Vaccinex, inc. (VCNX)
CashFlow / Yearly
Dec'19Dec'18Dec'17
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-31,863

-29,518

-18,759

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

249

223

206

Amortization of debt discount

-

308

1,217

Net amortization of premiums and discounts on marketable securities

44

100

-

Stock-based compensation

447

177

319

Change in fair value of derivative liabilities

-

369

3,743

Loss on extinguishment of related party convertible promissory note

-

-2,379

-

Changes in operating assets and liabilities:
Accounts receivable

260

522

13

Prepaid expenses and other current assets

-725

384

330

Accounts payable

725

421

-555

Accrued expenses

-694

2,407

-27

Deferred revenue

-

-298

298

Net cash used in operating activities

-30,715

-25,276

-21,387

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of marketable securities

-

20,756

-

Sales of marketable securities

14,151

6,750

-

Purchase of property and equipment

78

235

68

Net cash (used in) provided by investing activities

14,073

-14,241

-68

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible promissory notes to related parties, net of issuance cost

-

-

9,977

Proceeds from initial public offering of common stock, net of commissions and underwriting discounts

-

37,125

-

Proceeds from private offering of common stock

13,800

-

-

Payments of initial public offering costs

-

2,675

-

Proceeds from exercise of stock options

-

5

15

Repayment of convertible promissory note, related party

-

5,500

6,000

Proceeds from capital contribution

-

12,000

12,000

Net cash provided by financing activities

13,800

40,955

23,974

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-2,842

1,438

-

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest

-

275

13

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

2,519

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Purchase of property and equipment in accounts payable

161

-

-

Purchase of property and equipment included in accounts payable

-

-

9

Conversion of redeemable convertible preferred stock into common stock

-

111,718

-

Conversion of convertible preferred stock into common stock

-

7,684

-

Series D Redeemable Convertible Preferred Stock [Member]
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs

-

-

7,982